ArticleImmunologic research2019

Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.

Bahareh Kashani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.